Trial NCT02992418

View at ClinicalTrials.gov 
Org. Study IDs: CYD66
Secondary IDs: 2019-003136-23 U1111-1161-3294

Last trial update was posted on 2022-03-25

MeSH Interventions

Vaccines

MeSH Conditions

Dengue Fever Hemorrhagic Fevers, Viral Hyperthermia Severe Dengue

Other Conditions

Dengue Fever Dengue Hemorrhagic Fever

Stopping Reasons

No answer received from the Philippines Food and Drug Administration on protocol amendment issued due to IDMC recommendations. CYD vaccine 3rd dose not given.

Limitations And Caveats

Due to absence of response of competent authorities from The Philippines on protocol amendment, the study was prematurely terminated before injection of last dose (3rd dose) of the CYD dengue vaccine. Objectives related to 3rd dose were not assessed.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID